Afghanistan vs Malawi: Hepatitis B surface antigen (HBsAg) prevalence
Afghanistan
0.3%
in 2024
Malawi
0.3%
in 2024
Afghanistan rank
71st
Malawi rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Afghanistan
- Malawi
How they compare
Afghanistan currently reports 0.3% against 0.3% in Malawi, a difference of 0.0%.
Across all 10 years both countries report, Malawi has been ahead every year.
Afghanistan ranks 71st and Malawi ranks 71st of 194 countries.
Malawi has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.5% | 0.2% | Malawi |
| 2020s | 0.3% | 0.4% | 0.1% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Afghanistan or Malawi?
- Afghanistan, at 0.3% against 0.3% in Malawi as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Afghanistan and Malawi?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Malawi?
- 10 years are reported by both, from 2015 to 2024.
- How do Afghanistan and Malawi rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Afghanistan ranks 71st and Malawi ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.